Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Which has more risk and volatility, CRON or CPH?

Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500.

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-4.40%	-3.73%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Does the media favor CRON or CPH?

In the previous week, Cronos Group had 1 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 3 mentions for Cronos Group and 2 mentions for Cipher Pharmaceuticals. Cipher Pharmaceuticals' average media sentiment score of 0.00 beat Cronos Group's score of -0.09 indicating that Cipher Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cipher Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in CRON or CPH?

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 61.99% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%
Cipher Pharmaceuticals	Outperform Votes 181 61.99%	Underperform Votes 111 38.01%

Do institutionals and insiders believe in CRON or CPH?

16.0% of Cronos Group shares are owned by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Do analysts prefer CRON or CPH?

Cronos Group currently has a consensus price target of C$3.54, indicating a potential upside of 48.12%. Cipher Pharmaceuticals has a consensus price target of C$14.75, indicating a potential upside of 21.10%. Given Cronos Group's higher possible upside, equities analysts plainly believe Cronos Group is more favorable than Cipher Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Which has preferable earnings & valuation, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$76.86M	8.21	-C$32.78M	-C$0.18	-13.30
Cipher Pharmaceuticals	C$19.03M	11.49	C$11.41M	C$0.91	13.45

Summary

Cipher Pharmaceuticals beats Cronos Group on 14 of the 19 factors compared between the two stocks.